Errata

Erratum to: High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study

Erratum to Swiss Med Wkly. 2022;152:w30122 (DOI 10.4414/smw.2022.w30122)

DOI: https://doi.org/10.4414/smw.2022.w30149
Publication Date: 01.02.2022
Swiss Med Wkly. 2022;152:w30149

Please find the affiliations for this article in the PDF.

A reference in the discussion section was missing in the original article: at the end of the sentence "A recent published study assessed during the first pandemic
wave the SARS-CoV-2 seroprevalence, COVID-19
symptoms, and comorbidity among OAT patients from one
addiction outpatient unit in Dublin, Ireland" the article "Fenton F, Stokes S, Eagleton M. A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment. Ir J Med Sci. 2021. DOI 10.1007/s11845-021-02660-w" should have been cited. The original article has been corrected and the reference [15] added. 

This correction has been made to the online version as of February 1, 2022.

Verpassen Sie keinen Artikel!

close